Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03192267 · ClinicalTrials.gov registry record

Early Rheumatoid Arthritis Lung Disease Study

A clinical trial of Rheumatoid Arthritis, sponsored by University of Nebraska.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT03192267 is a study of Rheumatoid Arthritis that is actively recruiting participants, run by University of Nebraska. The registered enrollment target is 100 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03192267, a study of Rheumatoid Arthritis, is actively recruiting participants, sponsored by University of Nebraska.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

Extra-articular (outside of joints) disease occurs in approximately 50% of rheumatoid arthritis (RA) patients, with the lung being a common site of involvement. The goals of this study are to investigate and characterize lung disease and its prevalence in early RA participants. This will be done through pulmonary function and high resolution chest computed tomography (CT), questionnaires, and serum studies. Another goal is to find novel biomarkers, such anti-malondialdehyde-acetaldehyde (MAA) antibodies, as predictors of lung disease in RA participants.

Conditions Studied

Study Locations (1)

Nebraska

  • University of Nebraska Medical Center - Omaha

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2017-03-31
Est. Completion 2029-03

Sponsor

University of Nebraska

407 total trials

What the Registry Record Tells You About NCT03192267

The ClinicalTrials.gov registry entry for NCT03192267 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (98% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 0 interventions.

NCT03192267 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT03192267 about?

NCT03192267 is a clinical study titled "Early Rheumatoid Arthritis Lung Disease Study". Extra-articular (outside of joints) disease occurs in approximately 50% of rheumatoid arthritis (RA) patients, with the lung being a common site of involvement. The goals of this study are to investigate and characterize lung disease and its prevalence in early RA participants. This will be done thr...

What is the current status of trial NCT03192267?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2017-03-31. Estimated completion is 2029-03.

What conditions does trial NCT03192267 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis.

Who is sponsoring clinical trial NCT03192267?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03192267 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.